Abstract
Induced pluripotent stem cells (iPSCs) offer immense potential for treating central nervous system (CNS) disorders and injuries. However, the lack of highly sensitive, selective, and noninvasive biosensors for real-time monitoring of iPSC neuronal differentiation remains a critical barrier. In this work, we introduce a gold nanorod-based metal-enhanced molecular beacon (MEMB) nanobiosensor for the noninvasive, real-time detection of intracellular miRNA-124, a key biomarker for neuronal differentiation in human iPSC-derived neural stem cells. Designed through finite-difference time-domain (FDTD) simulations and experimentally validated for optimized localized surface plasmon resonance (LSPR) properties, MEMB nanobiosensors achieved picomolar-level sensitivity and single-mismatch selectivity toward miRNA-124 detection, along with great biocompatibility demonstrated by live-cell assays. Collectively, the MEMB platform provides a robust analytical tool for in-depth investigations of molecular and genetic regulatory networks during iPSC neuronal differentiation in a nondestructive manner, paving the way toward safer, more efficient, and better-characterized iPSC-derived cell therapies for CNS diseases and injuries.
Funding Information
  • National Key Research and Development Program of China (2024YFA1108200)
  • Alzheimer's Association (AARG-NTF-21-847862)
  • Congressionally Directed Medical Research Programs (OC220235P1)
  • Fundamental Research Funds for the Central Universities (22120240435)
  • New Jersey Commission on Spinal Cord Research (CSCR16ERG019, CSCR24IRG005)
  • National Natural Science Foundation of China (32301106)
  • National Institutes of Health (1R01NS130836- 01A1, R21 NS132556-01, RM1 NS133003-01)
  • Institutions of Higher Learning in Shanghai